artesunic acid has been researched along with Lymphoma, Non-Hodgkin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gao, J; He, Z; Jia, Y; Tao, H; Wang, F; Wu, P; Zhang, X; Zhou, Z | 1 |
1 other study(ies) available for artesunic acid and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway.
Topics: Apoptosis; Artesunate; Cell Line, Tumor; Ferroptosis; Humans; Lymphoma, Non-Hodgkin; Sorafenib; STAT3 Transcription Factor | 2023 |